Related Practices
- Duane Morris' South Florida Offices Add Three Intellectual Property Attorneys
- Duane Morris Adds to National Generic Pharmaceuticals Practice
- Duane Morris' Miami Office Adds Corporate Partner Mark S. Scott
- Duane Morris Partner Rick Ball to Speak at FDLI’s U.S.- China Food and Drug Law Conference
- Duane Morris Partners Vincent Capuano, Robert Gould and Richard Ruzich to Present at American Conference Institute's 5th Annual Paragraph IV Disputes Conference
- Duane Morris Partner Nick Lynn to Speak at the Health Care Compliance Association's 15th Annual Compliance Institute
- FDA Sends Prescription Drug User Fee Act V to Congress for Reauthorization
- U.S. Court of Appeals for the District of Columbia Circuit Determines That FDA Warning Letters Are Not Final Agency Action
- FDA Issues Proposed Rule Regarding Citizen Petitions and PSAs Related to Section 505(b)(2) Applications or ANDAs
Related Matters Listing
Attorney Listing
Pharmaceutical & Biotechnology
From major multinational corporations seeking to expand market share to startups with ideas growing in the laboratory, life sciences companies of all levels of maturity turn to Duane Morris for counsel and representation aimed at improving their organizational health.
Our attorneys are experienced with the challenges posed by the development, manufacture, marketing and sales of medical devices, technology and drugs, and work with clients to quickly and effectively clear regulatory hurdles while striving to protect intellectual and monetary assets.
Working at the crossroads of science and business, many Duane Morris lawyers call upon their knowledge gained through previous positions as toxicologists, pharmacists and laboratory researchers, as well as their advanced degrees in biology, biochemistry and molecular and developmental genetics, when assessing clients' specialized legal needs.
Drawing from our hundreds of attorneys in numerous major markets, we are able to provide teams of lawyers who practice in diverse legal disciplines (such as patents and intellectual property, corporate finance and securities law, international trade and taxation, labor and employment law, products liability and other litigation), all of whom have experience handling matters for pharmaceutical and biotechnology clients.
For more information, please contact Nicholas J. Lynn or any of the group members referenced in the Attorney Listing.
